Skip to content
SBIR reauthorization, a top BIO priority, is passed by Congress
Reauthorization of federal seed funding, a top priority for BIO’s work with Congress, ...
Read More
BIO on the American Road in Puerto Rico: ‘Medicine Cabinet’ ready to reshore
Known as “America’s Medicine Cabinet,” Puerto Rico is working to maintain its leadership ...
Read More
BIG Summit themes: Resilient investment, MFN threat, patients in the center
The inaugural BIO Investment and Growth (BIG) Summit was a chance for leaders ...
Read More
BIG Summit panel breaks down risks and opportunities coming out of DC
Washington’s healthcare policy landscape is constantly evolving, and 2026 is shaping up to ...
Read More
The hidden layer of PBMs: What a recent investigation reveals
With health care affordability a top concern for many Americans, pharmacy benefit managers ...
Read More
Nearly half of Americans say insurers’ rules on access delayed, denied, or altered care
Americans are frustrated with the health care system for two reasons. First, it ...
Read More
EDITORS' CHOICE
BIO CEO testifies in hearing highlighting PBMs’ impact on drug prices
Pharmacy benefit managers (PBMs) were identified as a major driver behind higher prescription drug costs in a congressional hearing that featured testimony from BIO President ...
Read More
LATEST NEWS
Latest News
SBIR reauthorization, a top BIO priority, is passed by Congress
Reauthorization of federal seed funding, a top priority for BIO’s work with Congress, passed the House with hefty bipartisan support on March 17 and is ...
BIO's View
BIO on the American Road in Puerto Rico: ‘Medicine Cabinet’ ready to reshore
Known as “America’s Medicine Cabinet,” Puerto Rico is working to maintain its leadership in U.S. biotech production by becoming a hub for reshoring pharmaceutical manufacturing. ...
BIO Events
BIG Summit themes: Resilient investment, MFN threat, patients in the center
The inaugural BIO Investment and Growth (BIG) Summit was a chance for leaders in the biotech industry to catch up on domestic and international policy ...
BIO Events
BIG Summit panel breaks down risks and opportunities coming out of DC
Washington’s healthcare policy landscape is constantly evolving, and 2026 is shaping up to be another consequential year for the biotech industry. Some developments are positive, ...
BIO's View
The hidden layer of PBMs: What a recent investigation reveals
With health care affordability a top concern for many Americans, pharmacy benefit managers (PBMs) continue to stand at the center of the debate. Working with ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
Federal Policy
State Policy
BIO on the American Road in Puerto Rico: ‘Medicine Cabinet’ ready to reshore
Known as “America’s Medicine Cabinet,” Puerto Rico is working to maintain its leadership in U.S. biotech production by becoming a ...
Read More
International
Bio's View
BIO on the American Road in Puerto Rico: ‘Medicine Cabinet’ ready to reshore
Known as “America’s Medicine Cabinet,” Puerto Rico is working to maintain its leadership in U.S. biotech production by becoming a ...
Read More
